DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(16 sites)
United Kingdom
Belfast City Hospital, Belfast University Hospital Birmingham, Birmingham Bristol Haematology and Oncology Centre, Bristol Addenbrooke's Hospital, Cambridge Velindre Cancer Centre, Cardiff Age range
18 Years and older
Last updated November 2025